Provided by Tiger Trade Technology Pte. Ltd.

ASTRAZENECA PLC ADRhedged

53.28
0.0000
Volume:- -
Turnover:- -
Market Cap:1.60M
PE:- -
High:53.28
Open:53.28
Low:53.28
Close:53.28
52wk High:56.90
52wk Low:44.36
Shares:30.00K
Float Shares:10.00K
Volume Ratio:2.68
T/O Rate:- -
Dividend:0.58
Dividend Rate:1.08%
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

Astrazeneca PLC Stock Rises Monday, Outperforms Market

Dow Jones
·
Jun 30

AstraZeneca's Enhertu Gets EU Approval for HER2-Positive Solid Tumors

MT Newswires Live
·
Jun 29

AstraZeneca (AZN) Gets a Sell from Deutsche Bank

TIPRANKS
·
Jun 27

AstraZeneca’s Opemalirsen Renal Study Completion: What Investors Should Watch Next

TIPRANKS
·
Jun 27

Astrazeneca Climbs Friday, Outperforms Market

Dow Jones
·
Jun 27

AstraZeneca's Datroway Breast Cancer Treatment Gets Recommendation for EU Approval

MT Newswires Live
·
Jun 26

AstraZeneca reports Datroway recommended for approval in EU by CHMP

TIPRANKS
·
Jun 26

Astrazeneca PLC Stock Rises Thursday, Outperforms Market

Dow Jones
·
Jun 26

Dow Jones Top Company Headlines at 3 am ET: Anthropic Claims Alibaba Ran 'brazen' Campaign to Access Its Claude AI Model | Micron ...

Dow Jones
·
Jun 25

Dow Jones Top Company Headlines at 5 PM ET: Micron Shares Jump as Chip Shortage Projected to Last Beyond 2027 | New ...

Dow Jones
·
Jun 25

New Drugs are Replacing Chemo for Aggressive Breast Cancer

Dow Jones
·
Jun 25

AstraZeneca’s CHRONICLES COPD Study Completion: What It Means for AZN Investors

TIPRANKS
·
Jun 25

AstraZeneca Advances Tuesday, Outperforms Market

Dow Jones
·
Jun 24

AstraZeneca Slides Thursday, Underperforms Market

Dow Jones
·
Jun 19

AIM ImmunoTech Trial of Ampligen With AstraZeneca's Imfinzi to Treat Pancreatic Cancers Doses Last Patient

MT Newswires Live
·
Jun 18

AstraZeneca Advances Fixed-Dose Cholesterol Combo With New Phase I Bioavailability Data

TIPRANKS
·
Jun 18

Major Pharmaceutical Firms Replicate UK Strategy: Leveraging Investment Withdrawal to Pressure Germany and Ease European Drug Price Controls

Stock News
·
Jun 17

AstraZeneca Faces Low Bar for Success in Key Lung-Cancer Trial -- Market Talk

Dow Jones
·
Jun 16

Jefferies Remains a Buy on AstraZeneca (AZN)

TIPRANKS
·
Jun 16

Astrazeneca's Ultomiris Receives FDA Priority Review for IgA Nephropathy

MT Newswires Live
·
Jun 15